Peptide Research

Hexarelin: The Most Potent GHRP, and Why That Is Not Simply Good

Hexarelin produces the largest growth hormone response of the GHRP family. It also desensitises faster than the others and lacks the selectivity that makes ipamorelin attractive.

Peptide Library Editorial · March 17, 2026 · Updated August 30, 2026 · 3 min read

Hexarelin: The Most Potent GHRP, and Why That Is Not Simply Good — Peptide Library research guide

Hexarelin is a six-amino-acid growth hormone releasing peptide, and it produces the largest GH response of its family. It is also the one most associated with rapid desensitisation, and it lacks the selectivity that distinguishes ipamorelin.

Those three facts sit together, and reading only the first is how hexarelin gets misrepresented as simply the strongest option.

Not an approved drug. Hexarelin has no approved human indication in the US, EU, or UK and no established human dose. It is sold for laboratory research only, and nothing here is dosing guidance.

The GHRP family

Growth hormone releasing peptides act at the ghrelin receptor to prompt GH release. They differ mainly in potency and in what else they do alongside it.

Hexarelin

GHRP-2

Ipamorelin

Relative GH response

Highest

High

Moderate

Cortisol / prolactin

Raises

Raises somewhat

Selective — minimal

Desensitisation

Fastest

Moderate

Slowest

The reason ipamorelin is discussed so much more often despite a smaller response is that its selectivity is the property most people actually want. Potency without selectivity means getting the GH release plus everything else the receptor family does.

Desensitisation is the central issue

Continuous or frequent stimulation of the ghrelin receptor reduces its responsiveness. Hexarelin is the GHRP where this is reported most strongly, with diminishing response over comparatively short periods of use.

This is the same receptor-biology problem that appears with kisspeptin in the reproductive axis: a system built around pulsatile signalling responds poorly to constant stimulation. It is a property of how the receptors work, not a formulation problem to be engineered around.

The practical consequence. A compound whose effect diminishes with use is one where an early response does not predict a later one. That undermines the usual assumption that a schedule which worked initially will keep working.

What else it does

Beyond GH release, hexarelin has a research literature around cardiac tissue, where effects have been reported that appear independent of the growth hormone axis — mediated through CD36 rather than the ghrelin receptor.

That is genuinely interesting biology and the subject of ongoing work. It is also, notably, not what hexarelin is generally sold for.

The vial math

Supplied lyophilised, commonly in 5 mg vials, with figures discussed in micrograms.

Vial

BAC water

Concentration

100 mcg

200 mcg

300 mcg

5 mg

2 mL

2.5 mg/mL

4 units

8 units

12 units

5 mg

3 mL

1.67 mg/mL

6 units

12 units

18 units

5 mg

5 mL

1 mg/mL

10 units

20 units

30 units

As with every low-microgram compound, more diluent produces larger and more forgiving unit readings. The peptide calculator handles any combination.

Storage

Storage is the same as any reconstituted vial: 2–8 °C, protected from light, never frozen, and bounded by the shorter of peptide stability and the 28-day limit on bacteriostatic water. The bacteriostatic water guide covers the detail.

Frequently asked questions

Is hexarelin better than ipamorelin?

It produces a larger GH response and is less selective, raising cortisol and prolactin where ipamorelin largely does not. Which matters more depends on what you are trying to observe — "better" is not a property of the molecule.

Why does the effect fade?

Receptor desensitisation. The ghrelin receptor becomes less responsive with repeated stimulation, and hexarelin is the GHRP where this is reported most strongly.

Does it need to be paired with a GHRH analogue?

GHRPs and GHRH analogues act on different receptors, which is the rationale for pairing them. See the CJC-1295 and ipamorelin guide.

Research and educational use only. Peptide Library is an independent research and comparison platform and does not sell peptides. Nothing here is medical advice, dosing guidance, or a recommendation to administer any substance to a person or an animal. Consult a licensed clinician for anything concerning human health.

Sources

  1. 1. Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein — International Journal of Molecular Sciences (2023) Source PubMed

Author

Peptide Library Editorial

Editorial content from Peptide Library. Research and educational use only. Not medical advice.

Research smarter with Peptide Library.

Compare peptides, review vendor data, and use research calculators in one place.

Explore the Library

Research and educational use only. Not medical advice. Peptide Library does not sell peptides.